Sumalinog, Juryl B.
HRN: 22-08-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
CEFUROXIME 1.5GM (VIAL)
11/20/2022
11/26/2022
IVTT
1.5g On Call To OR Then 750mg
On Call To OR Then Q8
For Prophylaxis For Surgical Procedure
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes